Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice
Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice
复制标题
DOI:
10.1182/blood.v89.3.1100
复制
发表时间:
1997-02-01
期刊:
影响因子:
20.3
通讯作者:
Majewski, D
中科院分区:
文献类型:
--
作者:
Drobyski, WR;Majewski, D
T cells that express the alpha beta T-cell receptor are thought to be the T-cell population primarily responsible for facilitating alloengraftment. The role of gamma delta(+) T cells that comprise only a minority of mature T cells in promoting allogeneic engraftment, however, has not been extensively studied. The purpose of this study was to determine whether gamma delta T cells were capable of facilitating alloengraftment in murine recipients of major histocompatibility complex-mismatched marrow grafts. We developed a model where engraftment of C57BL/6 x 129/F2 (H-2(b)) marrow in sublethally irradiated (800 cGy) recipients (AKR/J, H-2(k)) is dependent on the presence of mature donor T cells in the marrow graft. In this model, donor T-cell engraftment was significantly augmented by as few as 1 x 10(5) cup T cells. The role of gamma delta T cells was then investigated using transgenic donors (C57BL/6 x 129 background) in which a portion of the T-cell receptor-beta chain gene was deleted by gene targeting so that these mice lack alpha beta T cells. Addition of 10 x 10(6) naive gamma delta T cells to T-cell depleted marrow grafts was required to significantly increase alloengraftment, although donor T cells averaged 100 day) complete donor engraftment, indicating that limiting numbers of alpha beta T cells were required in the marrow graft for the eradication of residual host T cells. Using serial weight curves and B-cell reconstitution as end points, clinically significant graft-versus-host disease was not observed in these chimeras under these experimental conditions. These data show that, whereas less potent than alpha beta T cells, gamma delta T cells are able to promote engraftment and enhance hematopoietic reconstitution in allogeneic marrow transplant recipients. (C) 1997 by The American Society of Hematology.